Oxysterols and Alzheimer's disease.

I. Bjorkhem, M. Heverin, V. Leoni, S. Meaney, U. Diczfalusy

Research output: Contribution to journalArticle

Abstract

There is a clear link between cholesterol turnover and neurodegenerative diseases and hypercholesterolemia is an established risk factor for Alzheimer's disease (AD). The failure to demonstrate a transfer of cholesterol from the circulation into the brain in humans and experimental animals makes it difficult to explain the link between hypercholesterolemia and AD. In contrast to cholesterol itself, side-chain oxidized cholesterol metabolites such as 24S-hydroxycholesterol and 27-hydroxycholesterol are able to pass the blood-brain barrier (BBB). Formation of 24S-hydroxycholesterol is the quantitatively most important mechanism for elimination of cholesterol from the brain and we recently demonstrated a significant net uptake of 27-hydroxycholesterol by the brain from the circulation. We have also shown that patients with AD have increased brain levels of 27-hydroxycholesterol, which may affect the production of beta-amyloid in the brain. The levels of 27-hydroxycholesterol in the circulation are correlated with the levels of cholesterol and the possibility must be considered that the flux of 27-hydroxycholesterol into the brain is the missing link between hypercholesterolemia and Alzheimer's disease. Current knowledge about the role of the two oxysterols for cholesterol homeostasis in the brain as well as their diagnostic potential are reviewed.

Original languageEnglish
Pages (from-to)43-49
Number of pages7
JournalActa Neurologica Scandinavica, Supplement
Volume185
Publication statusPublished - 2006

Fingerprint

Alzheimer Disease
Cholesterol
Brain
Hypercholesterolemia
Oxysterols
Blood-Brain Barrier
Amyloid
Neurodegenerative Diseases
Homeostasis
27-hydroxycholesterol
24-hydroxycholesterol

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Bjorkhem, I., Heverin, M., Leoni, V., Meaney, S., & Diczfalusy, U. (2006). Oxysterols and Alzheimer's disease. Acta Neurologica Scandinavica, Supplement, 185, 43-49.

Oxysterols and Alzheimer's disease. / Bjorkhem, I.; Heverin, M.; Leoni, V.; Meaney, S.; Diczfalusy, U.

In: Acta Neurologica Scandinavica, Supplement, Vol. 185, 2006, p. 43-49.

Research output: Contribution to journalArticle

Bjorkhem, I, Heverin, M, Leoni, V, Meaney, S & Diczfalusy, U 2006, 'Oxysterols and Alzheimer's disease.', Acta Neurologica Scandinavica, Supplement, vol. 185, pp. 43-49.
Bjorkhem I, Heverin M, Leoni V, Meaney S, Diczfalusy U. Oxysterols and Alzheimer's disease. Acta Neurologica Scandinavica, Supplement. 2006;185:43-49.
Bjorkhem, I. ; Heverin, M. ; Leoni, V. ; Meaney, S. ; Diczfalusy, U. / Oxysterols and Alzheimer's disease. In: Acta Neurologica Scandinavica, Supplement. 2006 ; Vol. 185. pp. 43-49.
@article{d5478dd0a6bf45ee8ddb98e96e5a12e7,
title = "Oxysterols and Alzheimer's disease.",
abstract = "There is a clear link between cholesterol turnover and neurodegenerative diseases and hypercholesterolemia is an established risk factor for Alzheimer's disease (AD). The failure to demonstrate a transfer of cholesterol from the circulation into the brain in humans and experimental animals makes it difficult to explain the link between hypercholesterolemia and AD. In contrast to cholesterol itself, side-chain oxidized cholesterol metabolites such as 24S-hydroxycholesterol and 27-hydroxycholesterol are able to pass the blood-brain barrier (BBB). Formation of 24S-hydroxycholesterol is the quantitatively most important mechanism for elimination of cholesterol from the brain and we recently demonstrated a significant net uptake of 27-hydroxycholesterol by the brain from the circulation. We have also shown that patients with AD have increased brain levels of 27-hydroxycholesterol, which may affect the production of beta-amyloid in the brain. The levels of 27-hydroxycholesterol in the circulation are correlated with the levels of cholesterol and the possibility must be considered that the flux of 27-hydroxycholesterol into the brain is the missing link between hypercholesterolemia and Alzheimer's disease. Current knowledge about the role of the two oxysterols for cholesterol homeostasis in the brain as well as their diagnostic potential are reviewed.",
author = "I. Bjorkhem and M. Heverin and V. Leoni and S. Meaney and U. Diczfalusy",
year = "2006",
language = "English",
volume = "185",
pages = "43--49",
journal = "Acta psychiatrica et neurologica. Supplementum",
issn = "0065-1427",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Oxysterols and Alzheimer's disease.

AU - Bjorkhem, I.

AU - Heverin, M.

AU - Leoni, V.

AU - Meaney, S.

AU - Diczfalusy, U.

PY - 2006

Y1 - 2006

N2 - There is a clear link between cholesterol turnover and neurodegenerative diseases and hypercholesterolemia is an established risk factor for Alzheimer's disease (AD). The failure to demonstrate a transfer of cholesterol from the circulation into the brain in humans and experimental animals makes it difficult to explain the link between hypercholesterolemia and AD. In contrast to cholesterol itself, side-chain oxidized cholesterol metabolites such as 24S-hydroxycholesterol and 27-hydroxycholesterol are able to pass the blood-brain barrier (BBB). Formation of 24S-hydroxycholesterol is the quantitatively most important mechanism for elimination of cholesterol from the brain and we recently demonstrated a significant net uptake of 27-hydroxycholesterol by the brain from the circulation. We have also shown that patients with AD have increased brain levels of 27-hydroxycholesterol, which may affect the production of beta-amyloid in the brain. The levels of 27-hydroxycholesterol in the circulation are correlated with the levels of cholesterol and the possibility must be considered that the flux of 27-hydroxycholesterol into the brain is the missing link between hypercholesterolemia and Alzheimer's disease. Current knowledge about the role of the two oxysterols for cholesterol homeostasis in the brain as well as their diagnostic potential are reviewed.

AB - There is a clear link between cholesterol turnover and neurodegenerative diseases and hypercholesterolemia is an established risk factor for Alzheimer's disease (AD). The failure to demonstrate a transfer of cholesterol from the circulation into the brain in humans and experimental animals makes it difficult to explain the link between hypercholesterolemia and AD. In contrast to cholesterol itself, side-chain oxidized cholesterol metabolites such as 24S-hydroxycholesterol and 27-hydroxycholesterol are able to pass the blood-brain barrier (BBB). Formation of 24S-hydroxycholesterol is the quantitatively most important mechanism for elimination of cholesterol from the brain and we recently demonstrated a significant net uptake of 27-hydroxycholesterol by the brain from the circulation. We have also shown that patients with AD have increased brain levels of 27-hydroxycholesterol, which may affect the production of beta-amyloid in the brain. The levels of 27-hydroxycholesterol in the circulation are correlated with the levels of cholesterol and the possibility must be considered that the flux of 27-hydroxycholesterol into the brain is the missing link between hypercholesterolemia and Alzheimer's disease. Current knowledge about the role of the two oxysterols for cholesterol homeostasis in the brain as well as their diagnostic potential are reviewed.

UR - http://www.scopus.com/inward/record.url?scp=33846362273&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846362273&partnerID=8YFLogxK

M3 - Article

C2 - 16866910

AN - SCOPUS:33846362273

VL - 185

SP - 43

EP - 49

JO - Acta psychiatrica et neurologica. Supplementum

JF - Acta psychiatrica et neurologica. Supplementum

SN - 0065-1427

ER -